Completion requirements
View
9. References
- European Medicines Agency , 2012. Questions and answers on biosimilar medicines (similar biological medicinal products. Available from: https://www.medicinesforeurope.com/wp-content/uploads/2016/03/WC500020062.pdf (Accessed 3 March 2014).
- US Food and Drug Administration , 2014. What is a biological product? Available from: https://www.fda.gov/files/drugs/published/Biological-Product-Definitions.pdf (Accessed 3 March 2014).
- Mayo Clinic, 2013. Diabetes : definition. Available from: http://www.mayoclinic.org/diseases-conditions/diabetes/basics/definition/con-20033091 (Accessed 3 March 2014).
- Mayo Clinic, 2013. Diabetes: definition. Available from: http://www.mayoclinic.org/diseases-conditions/diabetes/basics/treatment/con-20033091 (Accessed 3 March 2014).
- Patient .co.uk, 2012. Neutropenic patients and neutropenic regimes. Available from: Neutropenic Patients and Neutropenic Regimes (Neutropenia) | Patient (Accessed 3 March 2014).
- Macmillan, 2013. G-CSF (granulocyte-colony stimulating factor). Available from: http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Supportivetherapies/HaematopoieticGrowthFactors.aspx (Accessed 3 March 2014).
- American Cancer Society, 2013. Monoclonal antibodies. Available from: Monoclonal Antibodies and Their Side Effects | American Cancer Society (Accessed 3 March 2014).
- Mayo Clinic, 2014. Monoclonal antibody drugs for cancer: how they work. Available from: http://www.mayoclinic.org/diseases-conditions/cancer/in-depth/monoclonal-antibody/art-20047808 (Accessed 3 March 2014).